openPR Logo
Press release

Infertility Treatment Market 2023 Expected CAGR 4.6% | Top Key Players are Halotech DNA, SCSA Diagnostics, Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences and More

01-14-2019 07:43 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Infertility Treatment Market

Infertility Treatment Market

Market Scenario:

The most common causes of infertility include deficiencies in semen or egg production such as poor quality and sperm motility, lower hormonal levels, abnormal ejaculation and even psychological conditions. As per Market Research Future (MRFR)’s analysis, the market for infertility stood at 11.2 billion in 2016, and is projected to expand at a CAGR of 4.6 % during the forecast period ending 2023.

Key players of Global Infertility Treatment Market:

Halotech DNA, SCSA Diagnostics, Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences, Aetna Inc., Bayer Healthcare, and EMD Serono, Inc.,

Get Dynamic Sample Copy @ https://www.marketresearchfuture.com/sample_request/6145

Market Dynamics:

Rise in Risk Factors Is the Prime Reason for Market Growth

The increase in risk factors for the global infertility market is sedentary lifestyles, increasing age at marriage, substance abuse, environmental factors, genetic abnormalities, stress, obesity, prostate cancer, varicocele, and others. Smoking, alcohol, anabolic steroid use, and illicit drug use is positively correlated to the growth of infertility. Cancer treatment such as chemotherapy, radiation, also affects fertility. Late marriage and hormonal disorders are other causes associated with infertility. Women infertility is caused by Polycystic ovary syndrome (PCOS), Functional hypothalamic amenorrhea, pelvic infection, ruptured appendicitis, gonorrhea or chlamydia, endometriosis, or abdominal surgery.

Growth in Awareness and Growing Number of fertility Clinics Is Driving a Large Demand

There has been a keen awareness regarding infertility with concurrent development of fertility clinics. The advent of assisted reproductive techniques has resulted in a significant adoption of these services by the market.

Poor Efficacy of Treatment and High Cost Sssociated May Hamper Market’s Growth

The prime market constraints include the high cost of the procedure, side effects of the drug therapy and social taboos for Infertility treatment and others.

Segments:

To gauge an accurate understanding of the market potentiality, the report is segmented by sex, diagnosis, drugs, techniques, and regions.

Based on the sex, the market is bifurcated as males, females and unexplained.

Based on the diagnosis, the market is bifurcated as men diagnostic tests (semen analysis, genetic testing, testicular biopsy, and other), women diagnostic tests (hysteroscopy, laparoscopy, ovulation testing, hysterosalpingography and others), and general diagnostic tests (genetic testing, hormone testing, microscopic analysis, imaging, and others)

Based on drugs, the market is segmented into clomiphene citrate, letrozole, serophene, hormone treatment and others.

Based on techniques, the market is segmented by assisted reproductive technology (ART), intrauterine insemination, and surgery. The surgery segment is further sub-segmented by laparoscopic or hysteroscopic surgery, tubal surgeries and others.

Based on geography, the market is charted according to North America, Europe, Asia Pacific, Middle East, and Africa.

Access Report @ https://www.marketresearchfuture.com/upcoming-reports/infertility-market-6145

Regional analysis

The US accounts for the maximum market share of the global infertility market attributed to increasing pool of awareness, high income, and good reimbursement scenario. Europe led by Germany, France, and the U.K. is expected to be the second largest market. Advancing technologies within the Infertility treatment is driving the market and will see strategic growth over the next five years. The Asia Pacific, dominated by China, and India is projected to be the fastest growing market owing to a large population with unmet needs and also because the rate of male infertility is highest in South Asia.

...

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infertility Treatment Market 2023 Expected CAGR 4.6% | Top Key Players are Halotech DNA, SCSA Diagnostics, Inc., Andrology Solutions, Zydus Cadila Healthcare Ltd, Androvia LifeSciences and More here

News-ID: 1493459 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Infertility

Shaping the Female Infertility Market in 2025: Rising Infertility Trends Driving …
How Big Is the Female Infertility Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been a regular expansion in the market size of female infertility. The market is predicted to increase from $1.79 billion in 2024 to $1.87 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.5%. The reasons behind the growth during the historic period include the rising trend
Infertility Treatment Market - Unveiling the Path to Fulfillment: Transforming L …
Newark, New Castle, USA - new report, titled Infertility Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Infertility Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Infertility Treatment market. The report offers an overview of the market, which
Male Infertility Market Size Analysis, Industry Outlook, Regional Forecast 2021- …
Idiopathic infertility and varicocele infertility are the two most common types of male infertility. Surgery, treatment for intercourse issues, hormone treatment, and ART technologies are the most common therapies for male infertility. The global rate of infertility is steadily rising in both developed and developing countries. The global Male Infertility market size is projected to reach US$ 3773.8 million by 2027, from US$ 2738.4 million in 2020, at a CAGR
Infertility Drugs Market Increasing Research & Development for More Effective Tr …
Infertility is a global health issue as its affects both men and women. Infertility in females occur due to increasing age, polycystic ovarian syndrome (PCOS), obesity, and multiple miscarriages whereas in males infertility occur due to erectile dysfunction, low sperm count, abnormal sperms, etc. Increasing prevalence of infertility is expected to propel demand for the infertility drugs. According to World Health Organization (WHO) 2012 report, infertility affects one out of
Global Infertility Drug Pipeline Analysis
The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing
Female Infertility-Pipeline Insights, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Female Infertility-Pipeline Insights, 2017 “Female Infertility-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Female Infertility. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III